| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |